Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1980 | 12-1979 | 12-1978 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 31,771 | 28,634 | N/A |
| Marketable Securities | 170,574 | 147,005 | N/A |
| Receivables | 544,658 | 432,289 | N/A |
| Inventories | 672,526 | 612,631 | N/A |
| Other current assets | 118,125 | 96,474 | 0 |
| TOTAL | $1,537,654 | $1,317,033 | $N/A |
| Non-Current Assets | |||
| PPE Net | 849,034 | 679,742 | N/A |
| Investments And Advances | 98,500 | 126,738 | 0 |
| Other Non-Current Assets | 122,264 | 82,665 | 0 |
| TOTAL | $1,069,798 | $889,145 | $N/A |
| Total Assets | $2,607,452 | $2,206,178 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 109,462 | 104,804 | 0 |
| Accrued Expenses | 105,104 | 116,036 | N/A |
| Other current liabilities | 243,283 | 145,770 | N/A |
| TOTAL | $738,781 | $533,447 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 32,862 | 8,211 | N/A |
| TOTAL | $133,578 | $86,569 | $N/A |
| Total Liabilities | $872,359 | $620,016 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 47,363 | 47,342 | N/A |
| Retained earnings | 1,577,061 | 1,445,522 | N/A |
| Other shareholders' equity | -38 | 165 | 0 |
| TOTAL | $1,735,093 | $1,586,162 | $N/A |
| Total Liabilities And Equity | $2,607,452 | $2,206,178 | $0 |